Helus Pharma (HELP) stock

Mental health medicines , market cap $613M

Medicines for depression and anxiety

Worth $613M

$9.07

-3.20%

As of Tuesday's close · Live for Pro members at the open

Why is HELP down?

Down 3.2% today, more than its biotech peers' 1.4%; no story names it yet.

Fell on Oct 22

Down 3% on Oct 22.

Our sources do not explain the move yet.
The S&P 500 fell 1.2% that day.

Sources: Price history, Oct 22, 2026

Tell me next time HELP moves

Free account, no card. An optional alert when HELP moves or its score changes.

Or see it live, free until Thursday morning. No account.

Quality Score

Below Average

In its industry

#92of 281

Biotech

Checks firing

0of 14

Transition

From 52-week high

-40.1%

under its best in a year

HELP's Quality Score fell 2 points on Tue, Nov 10, to 3. It closed away from its high of the day (2 chart checks stopped).

Follow HELP's news. Pro members can get an alert when Helus Pharma files news, and see its trials, share raises, and its CEO's filings.

Get an alert when HELP files newsSee it live, free until Thursday morning. No account. No card. Then keep going with a free account.

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

NextQ4 2026“…topline data from its Phase 3 APPROACH pivotal study of HLP003 in major depressive disorder in Q4 2026…”Trial data · SEC filing · Nov 6

Key facts on HELP

Key facts on HELP
Holding it back	Moves 9.6% a day with no recent filing behind it
Latest filing	6-K, Nov 6 Issued a release: "FORM 51-102F3 MATERIAL CHANGE REPORT Item 1. Name and Address of Company"

1 more reason behind HELP's 3, free with an account →2 more reasons behind HELP's 3, for Pro members.

HELP in the news

TodayNo story names it yet.

HELP catalysts

Coming up

What's next for HELP

Next step the company has named

Q4 2026“The Company continues to anticipate reporting topline data from its Phase 3 APPROACH pivotal study of HLP003 in major depressive disorder in Q4 2026.”Trial data · SEC filing · Nov 6

What it means: the first look at a trial’s main results, as the company reports them.

Lead program: HLP003

For Pro members: 2 more milestones and 156 filings.

Dilution on the horizon

No shelf registration or at-the-market program on file in the last three years.

For Pro members: the amounts, and the share count against a year ago.

Insiders

CFO Greg Cavers bought 3,000 shares on Sep 29. 7 more insider trades this year.

From Form 4: open-market buys and sales only.

Get an alert when Michael Halstead buys or sells

For Pro members: every trade, and Michael Halstead’s 7 filings and quotes.

Get an alert when HELP files newsA free account. No card.

See every upcoming FDA date →

FDA dates in the next 60 days

Decision dates and advisory committee meetings the companies have announced in their filings, soonest first and small companies first.

DateStockDrug

In 12 daysFDA decisionIn 12 days · FDA decisionCAPRCapricor TherapeuticsDeramiocelCAPRCapricor Therapeutics · $500MDeramiocelFDA decision due (PDUFA)
In 12 daysFDA decisionIn 12 days · FDA decisionSVRASavaraMolgramostimSVRASavara · $900MMolgramostimFDA decision due (PDUFA)
In 42 daysFDA decisionIn 42 days · FDA decisionMLYSMineralys TherapeuticsLorundrostatMLYSMineralys Therapeutics · $1.3BLorundrostatFDA decision due (PDUFA)

14 more FDA dates and 103 trial data dates in the next 60 days, each on the FDA calendar. Pro members see whether each company's cash lasts past its date, with an optional alert before it. See all 151 dates, ranked →

Why HELP scores 3

Below Averagefor quality, not price, 0 of 14 chart checks firingWhat the Quality Score means

+2Run-up 79% over 6 months
+3Insider trades Michael Halstead (Chief Executive Officer) bought $1.3M on Sep 21 near the 52-⁠week high. 4 insiders buying

Long-term trend adds
Profit subtractsRead on the last four quarters against the four before, or the last full year where no quarters are filed.
Volatility subtractsA daily range of 5% or more with nothing behind it (no profit or cash flow, sales shrinking, or 10% more shares outstanding with no free cash flow): -1, or -2 from 8%.

No effect today: Chart checks, Size, Growth, Dilution, Cash flow, Persistence, and News.

What every line is worth, and the reason behind it, on HELP and every other stock.Get in free →

Price, score, chart checks, and the industry rank are from a snapshot taken at 10:39 PM ET, at least 15 minutes behind. How we rank stocks.

Tested. Our top-scored stocks returned 2.2x the average stock over the next month. Reconstructed after the fact; recorded live since Sep 9, 2026. How we tested it

How HELP ranks in Biotech

HELP is #92 of 281 by Quality Score.

How HELP ranks in Biotech
Rank	Stock	Checks	Quality Score
1	ONCBeOne Medicines	8/14	24
2	VCELVericel	8/14	22
3	ETONEton Pharmaceutcials	9/14	20
	GPCRStructure Therapeutics		Open for its score
	HALOHalozyme Therapeutics		Open for its score
	HOWLWerewolf Therapeutics		Open for its score
	HRMYHarmony Biosciences		Open for its score
92	HELPHelus Pharma	0/14	3

When does HELP report earnings, and what happens after?

Expected to report Thu Nov 12, before the open (in 2 days).

What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.

Everyone reporting earnings this week

Nothing is firing on HELP right now

Trend1 of 5 shown

MA FAN 21 EMA W.EMA HH/HL 52W HI

Volume1 of 3 shown

VOL VDU U/D VOL

Tight range1 of 3 shown

ATR SQZ SQUEEZE NR7

Buying1 of 3 shown

OBV+CLOSE HI SPRING

The other 10 checks on HELP, and all 14 on every stock.Get in free →

HELP RSI today: 39.6, below its 50-day, above its 200-day

Not scored

RSI 39.6, MACD below signal, below its 50-day, above its 200-day. Not scored.13 readings

The deep dive on HELP

What it does and how it makes money1 findingFor Pro members1 finding on what HELP does and how it makes money, for Pro members
Who holds and trades it3 findingsInsiders bought $8.42M of shares on the open market in 90 days, with no sales; the largest, CEO Michael Halstead, bought $1.35M on Sep 21, 2026.Form 4, filed Sep 21, 2026

3 more findings on HELP, each with its source, for Pro members.

HELP insider trades

4 insiders bought $8.4M across 8 filings in the last 6 months. No open-⁠market sales on record. The newest:

BuyGreg Cavers$39KChief Financial Officerat $12.91 on Sep 29, filed Oct 1

BuyGreg CaversChief Financial Officer$39Kat $12.91 on Sep 29, filed Oct 1

All 8 insider filings on HELP from the last six months, for Pro members.

All HELP insider trades

HELP's officers and directors

Officers and directors with a Form 4 in the last 12 months.

Michael HalsteadChief Executive Officer · 1 trade
Greg CaversChief Financial Officer · 1 trade
Paul GlavineChief Growth Officer · 3 trades
Eric H. L. SoDirector · 3 trades

See insider trades by person

About Helus Pharma

Helus Pharma Inc, the commercial operating name of Cybin Inc, is a clinical-stage pharmaceutical company focused on developing proprietary neuroactive compounds, referred to as NSAs, which are synthetic molecules designed to target serotonin pathways. The company's programs are aimed at treating mental health conditions such as depression and anxiety. Its pipeline includes HLP003, which is in clinical development for the adjunctive treatment of depressive disorder, and HLP004, which is in clinical development for generalized anxiety disorder. The company also conducts research on additional investigational compounds.

50 employeeshelus.com

Here is what Pro members see.

The same page for Pro members, on Microsoft
Its Quality Score and rank, the line that drives it, and the live price.
The full chart
A year of candles to start, out to the whole history, with insider trades marked and the Quality Score under the price.
Every line of the score
Price action, the company, and signals, each with its points, on HELP and every other stock.
FDA dates, counted down
Each date in the company's words, its cash against the date, and an optional alert before it.
CEOs buying their own stock
Every CEO buy, biggest names first. Sort, filter, save the list, and set optional alerts.
Congress trades
A member's trades, newest first, each with its amount. Sort and filter the whole list.
14 chart checks, read for you
The ones firing on the stock, each in plain words, its rule a tap away.
Earnings, week by week
Who reports each day, and how each stock took its last four reports.
The market map
Every stock a box, colored by its Quality Score.
Themes, ranked live
Each theme's stocks ranked by Quality Score, live. Here, AI chips.
The top 10, every day
The ten highest Quality Scores at each close, kept day by day, week by week.
Optional alerts, your way
Pick a stock, a score, a price, a filing, or a whole scan. It tells you by push or email.
Your watchlist, scored
Your stocks by Quality Score, today's move, or name.
On your phone and your laptop
The same account and watchlist on both, each laid out for its screen.

Prices refresh every 2.5 seconds during market hours.
Optional alerts by push, email, or the bell.
Add it to your Home Screen and it opens like an app.

Pro members see every line of every stock's score.

What would turn HELP's score around: 5 things
9 more filings explained, a plain line each
Real-⁠time prices, no delay

BreakawayOct 1Greg Cavers bought HELP$39K at $12.91, filed Oct 1

Alerts are optional.

See HELP's 14 chart checks

See it live, free until Thursday morning. No account. No card. Then keep going with a free account.

Straight AnswersStraight Answers

As of Nov 10, 2026: HELP's Quality Score is 3 (Below Average), #92 of 281 in Biotech. Insiders bought $8.4M in the last 6 months (Form 4).

What does HELP's Quality Score say?

HELP scores 3 today, which Breakaway calls Below Average. It is #92 of 281 in Biotech by Quality Score, with 0 of 14 chart checks firing. Down 3% on Oct 22. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.

What is HELP's Quality Score?

HELP scores 3 today, which Breakaway calls Below Average (0 to 5). That is #92 of 281 in Biotech by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind HELP's 3.

Are insiders buying HELP?

4 insiders bought $8.4M across 8 filings in the last 6 months. No open-⁠market sales on record. The newest is Greg Cavers, Chief Financial Officer, who bought $39K on Sep 29. Every filing, with the scored weight, for Pro members.

Are the prices delayed?

Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.